ADA Scientific Sessions 2025 Abstract
Mazdutide vs. Placebo as Monotherapy in Patients with Type 2 Diabetes (DREAMS-1)
Trial in peopleInterventions
The paper
Nanjing
ADA Scientific Sessions 2025 Abstract, 13 Jun 2025
Presented at ADA Scientific Sessions 2025, oral 306-OR

